Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study to Isolate and Test Circulating Tumor Cells Using the ClearCell® FX EP+ System

NCT02370303 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT02370303
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02370303 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study to Isolate and Test Circulating Tumor Cells Using the ClearCell® FX EP+ System
Lead sponsor
Mayo Clinic
Phase
Observational
Overall status
Completed
Start date
August 31, 2014
Completion date
July 9, 2016
Enrollment
23 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adenocarcinoma, cancer of lung, cancer of the lung, carcinoma, non-small-cell lung, lung cancer, lung neoplasms, neoplasms, lung, neoplasms, pulmonary, pulmonary cancer, pulmonary neoplasms, squamous cell carcinoma